← SynDRA
BANOXANTRONE
SynDRA canonical compound SYN0004311 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
|---|
| Primary target(s) | TOP2A | TOP2B |
|---|
| Mechanism of action | topoisomerase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- topoisomerase inhibitor
- Modulator
Cross-references
Synonyms
- Banoxantrona
- AQ-4N
- AQ4N
- AQ4M
- AZD-1689
- AQ4N, AstraZeneca/Novacea
- AQ 4N
- banoxantrona
- W5H7E45YT3
- banoxantronum
- RefChem:116442
- DTXCID30817764
- Banoxantrone (AQ4N)
- Banoxantrone [INN:BAN]
- UNII-W5H7E45YT3
- BANOXANTRONE [INN]
- orb1738620
- SCHEMBL3676563
- SCHEMBL29378863
- YZBAXVICWUUHGG-UHFFFAOYSA-N
- GLXC-01796
- EX-A15485
- NCGC00346890-01
- HY-13562
- MS-33206
- DS-016089
- CS-0007169
- NS00069174
- MS-29599
- C22H30Cl2N4O6
- Banoxantrone (dihydrochloride)
- MMC06698
- AKOS024458040
- CS-6986
- orb1710327
- AQ4N dihydrochloride
- Banoxantrone dihydrochloride
- HY-13562A
- UNII-658876KMFP
Look up BANOXANTRONE in the interactive SynDRA portal →